Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England, 27 January 2021
www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/characteristicsofpeopletestingpositiveforcovid19inengland27january2021
Antigen survey
S-gene is no longer detected in the current test
Classic symptoms
Cough, fever, shortness of breath, loss of taste or loss of smell
New UK variant infections
Were more likely to report any symptoms
Largest difference, more reports of cough, sore throat, fatigue, myalgia, fever
More likely to report the classic symptoms
Significantly less likely to report loss of taste and smell
There is no evidence of difference in the gastrointestinal symptoms, shortness of breath or headaches.
UK
covid.joinzoe.com/data#levels-over-time
coronavirus.data.gov.uk
Cases, + 25,308 = 3,715,054
Hospitalisations, 3,082 = 37,605 (3,961)
Deaths, + 1,631 + 1,725 = 101,887
Deaths, + 7,766 = 103,602
Deaths will come down slowly
www.bbc.co.uk/news/uk-55818636
Prof Chris Whitty
a lot more deaths over the next few weeks
before the effects of vaccinations kick in
Current restrictions just about holding in lowering infection rates
Vaccinations
First dose, 7,164,387
Second dose, 474,156
Earliest English school return date, 8th March
UK travel
www.bbc.co.uk/news/uk-55821702
Quarantine in hotels, 10 days
30 high risk countries
Met at airport transported directly into quarantine
South America, South Africa, Portugal travellers already banned
Ban on travel for leisure
US, CDC data
covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases
Past 7 days
www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus
Cases, down 16.4%
Deaths, up 10.4%
Hospitalizations, down 10.4%
Positivity rate, 9.1%
Vaccinations
24,391,000 doses given
Completed courses, 3,529,000 (1.08%)
China
Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients (Future Medicine)
www.futuremedicine.com/doi/10.2217/fmb-2020-0090
ACE2 is most abundantly expressed on the surface of alveolar epithelial cells and small intestine epithelial cells
SARS-CoV-2 shed in the different phases of infection
Betacoronavirus genus, can cause respiratory, intestinal, liver and nervous system infections in animals and humans
www.washingtonpost.com/world/asia_pacific/anal-swab-china-coronavirus/2021/01/27/cc284f56-6054-11eb-a177-7765f29a9524_story.html
Recovering patients
Continued to test positive days after nasal and throat swabs were negative
Quarantine centers
Raise rate of identifying infected patients
Domestic travel
Lunar New Year next month
Travelers arriving from overseas
Two weeks of hotel quarantine
Plus a third week of home quarantine
Fourth week of daily reports to health officials
EU, Oxford AZ vaccine
www.bbc.co.uk/news/world-europe-55822602
Not yet approved by EMA
August ordered 300 million (+ 100 m) doses
Production delays, plants, Netherlands and Belgium
Two months behind
UK deal signed May
80 million doses expected by March
Reduced to 31 million, down 60% for first quarter
EU has threatened to restrict vaccine exports
EU, Pfizer/BioNTech
Order, 600 m doses
Delayed supplies for a few weeks
Sanofi will help produce 125 million doses in Frankfurt from July
Global vaccine tracker
www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/
UK vaccine tracker
coronavirus.data.gov.uk/details/vaccinations
US vaccine tracker
covid.cdc.gov/covid-data-tracker/#vaccinations
Europe vaccine tracker
data.spectator.co.uk/city/vaccines
27 янв 2021
